英文: Two alemtuzumab and three Thymoglobulin patients suffered rejection episodes.
中文: 阿仑单抗组有2例而抗胸腺细胞球蛋白组有3例发生排斥反应.英文: Alemtuzumab, a humanized anti-CD52 antibody, has shown promise in tolerogenic induction protocols, requiring minimal maintenance immunosuppression.
中文: 阿仑单抗,一种人源性抗-CD52抗体,在免疫耐受诱导方案中效果显著,需要最少的免疫抑制维持药物.